Interestingly, TMPO is expressed at slightly lower levels in the patient line, which is, on its own, known to be associated with the DCM in patients.25 By contrast, SYNE2 has higher expression levels in the patient line, indicating that there are compensation mechanisms. Here, SYNE2 is linked to familial dilated cardiomyopathy.